Evolution of the Average Target: Sartorius AG

Evolution of the Target Price: Sartorius AG

Changes in Analyst Recommendations: Sartorius AG

110f8654c5fe6cdde96a0ec2f55ab31e.v8SiCRhUQgpMAmpACW_a1YccHGgW9rWwLAishoyprRQ.6pvra1she1gnVQ1xRxmYke4qUTFSgcbWTlH4z_b71HXYi_RsYhovTHk7BQ~4d83adc85457947db5532ba9c2668039
06-23 SARTORIUS VORZUEGE : Goldman Sachs sticks Neutral ZD
06-23 Goldman Cuts Sartorius Target to €229, Keeps 'Neutral' DP
06-23 SARTORIUS VORZUEGE : DZ Bank reaffirms its Neutral rating ZD
06-22 SARTORIUS VORZUEGE : JP Morgan gives a Buy rating ZD
06-22 SARTORIUS VORZUEGE : Receives a Buy rating from Deutsche Bank ZD
06-08 Sartorius Kept at Sell as Mwb Notes 'More Visible' Pharma Capex Risk MT
06-05 Sartorius AG out of favor, as mwb research maintains Sell rating Zonebourse
06-05 Sartorius AG Out of Favor as mwb research Maintains Sell Rating Zonebourse
05-26 Sartorius AG Price Target, Estimates Down at AlphaValue/Baader Europe Post-FY26 Guidance MT
05-25 Sartorius: Trimming the new baseline Alphavalue
05-25 AlphaValue/Baader Europe Cuts Forecasts, Price Target for Sartorius Stedim Biotech on FY26 Outlook MT
05-06 SARTORIUS VORZUEGE : RBC remains Neutral ZD
04-27 Sartorius AG Edges Higher Despite Berenberg's Positive Call Zonebourse
04-27 SARTORIUS VORZUEGE : Goldman Sachs sticks Neutral ZD
04-27 SARTORIUS VORZUEGE : Raised to Buy by Berenberg ZD
04-27 Berenberg upgrades Sartorius to 'Buy' - Price target raised to 250 euros DP
04-24 SARTORIUS VORZUEGE : UBS gives a Neutral rating ZD
04-24 SARTORIUS VORZUEGE : DZ Bank gives a Neutral rating ZD
04-24 Sartorius: Resilient Q1; H2 recovery is the key watchpoint Alphavalue
04-23 SARTORIUS VORZUEGE : Barclays gives a Buy rating ZD
04-23 SARTORIUS VORZUEGE : Jefferies reiterates its Buy rating ZD
04-23 SARTORIUS VORZUEGE : RBC reiterates its Neutral rating ZD
04-23 SARTORIUS VORZUEGE : Bernstein remains its Buy rating ZD
04-23 SARTORIUS VORZUEGE : JP Morgan gives a Buy rating ZD
04-23 SARTORIUS VORZUEGE : UBS reaffirms its Neutral rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.69%
- - +78.89%
+43.41%
+37.76%
+92.62%
+74.93%
+41.51%
+22.49%
+28.06%
Average +48.37%
Weighted average by Cap. +26.27%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
230.20EUR
Average target price
266.32EUR
Spread / Average Target
+15.69%
High Price Target
307.00EUR
Spread / Highest target
+33.36%
Low Price Target
190.00EUR
Spread / Lowest Target
-17.46%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

DZ BANK Sven Kürten
GOLDMAN SACHS James Quigley
JPMORGAN Richard Vosser
alphavalue Jitisha Malhotra
RBC Charles Weston
BERENBERG Harry Gillis
UBS Matthew Weston
BERNSTEIN RESEARCH Delphine Le Louet
JEFFERIES James Vane-Tempest
BARCLAYS Charles Pitman-King
DEUTSCHE BANK RESEARCH Falko Friedrichs
Morningstar
WARBURG RESEARCH Michael Heider
AlphaValue/Baader Europe
ODDO BHF Oliver Metzger
CREDIT SUISSE Dominic Lunn
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
230.20EUR
Average target price
266.32EUR
Spread / Average Target
+15.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SRT3 Stock
  4. Consensus Sartorius AG